Health News Archive - July 07, 2010
LONDON, July 7 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,750,144, titled Methods and Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the United States Patent and Trademark Office (USPTO).
PARIS, July 7, 2010 /PRNewswire/ -- REQUEST - a group of European veterinary experts in anti-infective diseases - organised a specific session during the last WSAVA Congress in Geneva, the 4th of June 2010. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/vetoquinol/42450/ The objective was to deliver the first results of this group working on the proper use of Fluoroquinolones in companion animals.
DALLAS, Texas, July 7, 2010 /PRNewswire/ -- According to the new market research report, "Telemedicine Market in Brazil, Russia, India, China (BRIC) - Advanced technologies, Global Forecast" published by MarketsandMarkets (http://www.marketsandmarkets.com), the BRIC telemedicine is expected to reach a market size of $418.4 million by the year 2014, at a CAGR of 15.8% from 2009-2014.
BETHESDA, Md., July 7 /PRNewswire-USNewswire/ -- The Bladder Cancer Advocacy Network (BCAN), the first national advocacy organization dedicated to improving public awareness of bladder cancer, applauds U.S.
FOOTHILL RANCH, Calif., July 7 /PRNewswire-FirstCall/ -- Skilled Healthcare Group, Inc. (NYSE: SKH) today reported that a jury in Humboldt County, California, returned a verdict against the Company related to a complaint filed more than four years ago.
BEIJING, July 7 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has filed its annual report for the fiscal year ended December 31, 2009 on Form 20-F with the U.S.
DENVER, July 7 /PRNewswire/ -- Invision Sally Jobe is among the first diagnostic imaging networks in the nation to offer a new breast ultrasound technology for the early detection of cancer.
BETHESDA, M.D., July 7 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO), developer of the DCVaxÂ® personalized cancer vaccines, announced today that during the second quarter it raised funding of $2.65 million from investors.
A new study suggests that when patients are admitted to an intensive care unit on the weekend they may be more likely to die than those admitted on a weekday.
European children with high levels of bad cholesterol and triglycerides will soon have a new way to fight those health issues after the European Union approved a new chewable form of Lipitor, Pfizer said Tuesday.